Siemens Healthineers AG has a consensus price target of $0, established from looking at the 1 latest analyst ratings. The last 1 analyst ratings were released from Jefferies on September 8, 2021. With an average price target of - between Jefferies, there's an implied -100.00% downside for Siemens Healthineers AG from these 1 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
09/08/2021 | SMMNY | Buy Now | Siemens Healthineers | $30.67 | — | Jefferies | James VaneTempest | — | Initiates | → Hold | Get Alert |
The latest price target for Siemens Healthineers (OTCPK: SMMNY) was reported by Jefferies on September 8, 2021. The analyst firm set a price target for $0.00 expecting SMMNY to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for Siemens Healthineers (OTCPK: SMMNY) was provided by Jefferies, and Siemens Healthineers initiated their hold rating.
There is no last upgrade for Siemens Healthineers.
There is no last downgrade for Siemens Healthineers.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Siemens Healthineers, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Siemens Healthineers was filed on September 8, 2021 so you should expect the next rating to be made available sometime around September 8, 2022.
While ratings are subjective and will change, the latest Siemens Healthineers (SMMNY) rating was a initiated with a price target of $0.00 to $0.00. The current price Siemens Healthineers (SMMNY) is trading at is $30.67, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.